a b s t r a c t g-aminobutyric acid (GABA) begins as the key excitatory neurotransmitter in newly forming circuits, with chloride efflux from GABA type A receptors (GABA A Rs) producing membrane depolarization, which promotes calcium entry, dendritic outgrowth and synaptogenesis. As development proceeds, GABAergic signaling switches to inhibitory hyperpolarizing neurotransmission. Despite the evidence of impaired GABAergic neurotransmission in neurodevelopmental disorders, little is understood on how agonistdependent GABA A R activation controls the formation and plasticity of GABAergic synapses. We have identified a weakly depolarizing and inhibitory GABA A R response in cortical neurons that occurs during the transition period from GABA A R depolarizing excitation to hyperpolarizing inhibitory activity. We show here that treatment with the GABA A R agonist muscimol mediates structural changes that diminish GABAergic synapse strength through postsynaptic and presynaptic plasticity via intracellular Ca 2þ stores, ERK and BDNF/TrkB signaling. Muscimol decreases synaptic localization of surface g2 GABA A Rs and gephyrin postsynaptic scaffold while b2/3 non-g2 GABA A Rs accumulate in the synapse. Concurrent with this structural plasticity, muscimol treatment decreases synaptic currents while enhancing the g2 containing benzodiazepine sensitive GABA A R tonic current in an ERK dependent manner. We further demonstrate that GABA A R activation leads to a decrease in presynaptic GAD65 levels via BDNF/TrkB signaling. Together these data reveal a novel mechanism for agonist induced GABAergic synapse plasticity that can occur on the timescale of minutes, contributing to rapid modification of synaptic and circuit function.
Introduction
Synaptic development occurs first with the emergence of excitatory GABAergic signals that drive the subsequent establishment of glutamatergic responses Deng et al., 2007) . At this time, GABA depolarizes neurons due to a high intracellular chloride level ([Cl‾] i ) maintained by the cationchloride importer NKCC1. This depolarizing response relies on chloride efflux via GABA A Rs and leads to an increase in intracellular calcium ([Ca 2þ ] i ) through activation of voltage gated calcium channels and removal of magnesium block from NMDA receptors. The transition from a depolarizing to hyperpolarizing response occurs due to a rise in expression of the K-Cl extruder KCC2 that reduces [Cl‾] i (Kaila et al., 2014) , with in vitro cultured neuron and brain slice studies reporting the switch occurs in most brain areas (cerebellum, hypothalamus, cortex, hippocampus) during the second week of development (Ganguly et al., 2001; He et al., 2014; Mueller et al., 1984; Obrietan and van den Pol, 1995; Owens et al., 1996; Succol et al., 2012; Tyzio et al., 2007) . Depolarizing GABA A R responses during development and in the adult brain can either promote excitation or generate shunting inhibition, depending on the magnitude of depolarization (Chiang et al., 2012; Khalilov et al., 2015; Staley and Mody, 1992) . Importantly, two recent in vivo studies demonstrated that GABA primarily depolarizes and inhibits network activity in the intact neonatal cortex around P3-P9, although the timing of the developmental switch to a hyperpolarizing response in vivo was not identified (Kirmse et al., 2015; Valeeva et al., 2016) .
GABA A Rs are heteropentamers typically composed of two a (a1-6), two b (b1-3), and either a g (g1-3) or a d subunit (Olsen and Sieghart, 2008) . g2 subunits are expressed in 90% of GABA A Rs in the CNS (Lee and Maguire, 2014) , with the major subtype being a1b2g2, followed by the abundant a3b3g2 and a2b3g2 subtypes (Nutt, 2006) . Despite the great diversity of GABA A R subunits and possible configurations, these receptors produce two types of currents: synaptic (phasic) and tonic. Presynaptic terminal release of GABA onto postsynaptically clustered GABA A Rs triggers fast, transient synaptic currents, while ambient GABA that "spills over" results in activation of extrasynaptic receptors that generate a persistent tonic current. Subunit composition determines receptor cell surface localization as well as physiological and pharmacological properties. Receptors containing a1-a3 subunits are primarily located at GABAergic synapses via direct association with gephyrin (Mukherjee et al., 2011; Tretter et al., 2008 Tretter et al., , 2011 , the key GABAergic and glycinergic postsynaptic scaffolding protein, while the g2 subunit is required for maintenance of postsynaptic receptors and gephyrin (Essrich et al., 1998) . While predominantly clustered at synapses, g2 containing receptors are also found at extrasynaptic sites and contribute to tonic current that is sensitive to positive allosteric modulation by the benzodiazepine drug class (Prenosil et al., 2006) . Extrasynaptic g2 GABA A Rs play a significant role in tonic inhibition, with benzodiazepines able to enhance the level of the tonic current by approximately two fold (Korol et al., 2015) . Knockout of the g2 subunit removes 94% of the benzodiazepine binding sites in the brain and benzodiazepine potentiation of GABA currents (Gunther et al., 1995) . Although synaptic and extrasynaptic receptors are often described as distinct entities, single molecule tracking, electrophysiological, biochemical and other imaging based methods have revealed that receptors in both populations diffuse continually in the plasma membrane, with enhanced accumulation of synaptic receptors depending on interactions between gephyrin and GABA A R.
Many studies have improved our understanding of the formation of GABAergic synapses, however little is known about GABA A R agonist induced synaptic plasticity mechanisms. The aim of this study was to investigate the role of GABA A R activation in modulation of GABAergic synaptic plasticity after synapse establishment. Here we reveal that agonist induced GABAergic synaptic plasticity can occur on the timescale of minutes, contributing to rapid modification of synaptic and circuit function. Importantly, this depolarizing and inhibitory GABA A R response results in structural and functional synaptic changes that rely on release of intracellular Ca 2þ stores, ERK and BDNF/TrkB signaling.
Materials and methods

Neuron culture and transfection
All procedures were approved by the University of Pittsburgh Institutional Animal Care and Use Committee. Cortical neurons were prepared from embryonic day 18 rats and nucleofected (Lonza) at plating as needed (Jacob et al., 2005) .
Immunofluorescence, imaging and analysis of cells
Surface GABA A R g2 (Rbt, 1:1000, Synaptic Systems, #224003) or b2/3 (Mouse, 1:200, Millipore, MAB341) was done under nonpermeabilized conditions, followed by permeabilization and staining for endogenous gephyrin (Mouse, 1:300, Synaptic Systems, #147011 mAb7A), VIATT (Rbt 1:1000, Synaptic Systems, #131002), or GAD65 (Guinea pig, 1:500, Synaptic Systems, #198104) as previously described (Jacob et al., 2005) . Total and phospho ERK immunofluorescence studies used ERK antibody (Rabbit, 1:2000, Cell Signaling #9107) and phospho ERK antibody (Rabbit, 1:200, Cell Signaling #9102) . Drug treatments were performed as described in the Drug treatments and Western Blots section of the methods. Images were taken on a Nikon A1 Confocal microscope using a 60Â oil immersion objective (NA 1.49) at a 2Â zoom. Data were analyzed using NIS Elements software (Nikon, NY). In all immunofluorescence studies, 20 mm length regions of interest (ROIs) from two to three proximal dendrites per neuron were used for analysis. For ERK and phospho ERK measurements, the sum intensity was quantified for each ROI. For synaptic GABA A R and gephyrin measurements, a 1-bit binary image was made of the presynaptic GABAergic terminal marker (GAD65 or VIAAT) and only surface GABA A R or gephyrin fluorescence that colocalized with the synaptic binary were measured. For the total dendrite measurements, surface GABA A R, gephyrin, VIAAT or GAD65 fluorescence was quantified for the entire dendritic ROI. The value quantified is the sum fluorescence intensity: pixel intensity values within a given ROI or synaptic region are added, thus containing a combined measurement of area and intensity changes. For neuron immunofluorescence analysis and calcium imaging, 3-5 independent neuron cultures were used for each experiment. Finally, image acquisition and analysis was performed blind to experimental condition and laser settings for acquisition and thresholding values for analysis were kept constant between cultures.
Drug treatments and western blots
For muscimol only drug treatments, cortical neuronal cultures were treated for either 0 or 30 min in HEPES-buffered imaging solution (HBS) containing 135 mM NaCl, 4.7 mM KCl, 1.2 mM MgCl 2 , 10 mM HEPES, 2.5 mM CaCl 2 , 11 mM glucose, pH 7.4. Other drug treatments were performed as follows: 5 min pretreatment with 1 mM TTX or HBS control, then 0 or 30 min treatment with 50 mM muscimol; 30 min pretreatment with 1 mM U0126 or DMSO in HBS control, then 0 or 30 min treatment with 50 mM muscimol; 1 h pretreatment with 200 nM thapsigargin and 50 mM BAPTA-AM (TGBA) or DMSO in HBS control, then 0 or 30 min treatment with 50 mM muscimol; 30 min pretreatment with 10 mM Nimodipine or DMSO in HBS control, then 0 or 30 min treatment with 50 mM muscimol; 10 min pretreatment with 20 mM bicuculline or DMSO in HBS control; 30 min pretreatment with 10 mM ANA-12 or DMSO in HBS control, then 0 or 30 min treatment with 50 mM muscimol. For muscimol treatments with and without extracellular calcium, cells were pretreated for 30 min either in normal HBS or HBS eCa 2þ (0 mM CaCl 2 þ 1 mM EGTA), then treated with 50 mM muscimol for 0 or 30 min. For synaptic stimulation by KCl (50 mM KCl in HBS(equimolar substitution of KCl for NaCl: 89.7 mM NaCl, 50 mM KCl, 1.2 mM MgCl 2 , 10 mM HEPES, 2.5 mM CaCl 2 , 11 mM glucose, pH 7.4)), cells were washed once with HBS or HBS eCa 2þ and then were treated for 3 min with either HBS, HBS eCa 2þ , or KCl ± Ca 2þ (0 mM CaCl 2 þ 1 mM EGTA) solution. At the end of treatment, cells were lysed in RIPA buffer containing 50 mM Tris-HCl (pH 8.0), 50 mM NaCl, 1 mM EDTA, 1% Igepal, 0.5% sodium deoxycholate, 0.1% SDS, 10 mM NaF, 2 mM sodium orthovanadate, and protease inhibitor cocktail (Sigma, St. Louis, MO), solubilized for 20-30 min at 4 C, and spun at 15000 Â g for 15 min. For acute cortical slice experiments, slices were incubated in artificial cerebrospinal fluid (ACSF: 124 mM NaCl, 3 mM KCl, 25 mM NaHCO3, 2 mM CaCl2, 1.1 mM NaH2PO4, 2 mM MgSO4, 10 mM D-glucose) at 37 C for 1 h for recovery before experimentation. Slices from the same animal were then treated for either 0, 5 or 30 min in ACSF containing 50 mM muscimol, followed by lysis in homogenization buffer (20 mM Tris 7.4, 1 mM EDTA, 320 mM sucrose, 20 mM Na pyrophosphate, 10 mM NaF, 20 mM b-glycerophosphate) and centrifugation (1000 rcf for 10 min) to isolate the supernatant. A BCA protein assay was performed on the supernatant, and equivalent amounts of protein were loaded onto 8% Tris gels. After electrophoresis and transfer to nitrocellulose, samples were probed with primary antibody For western blot analysis of in vitro neuronal cultures 3-9 independent cultures were used for each experiment.
Ca2þ imaging and analysis
Primary rat cortical neurons were incubated in Fura 2-AM (3 mM; Molecular Probes, Eugene, OR, USA) for 60 min at 37 C in 5% CO 2 . Fura 2-AM was prepared in HBS containing bovine serum albumin (5 mg/ml: Sigma Aldrich) to promote dye loading. Calcium imaging was performed as described previously (Zhang et al., 2012) . Briefly, loaded coverslips were placed on an inverted epifluorescence microscope chamber (IX70; Olympus, Tokyo, Japan) and constantly perfused (2 ml/min) with saline by a gravity-driven Y-system. Fura-2 was excited by 340 nm and 380 nm UV light and fluorescence emission at 510 nM was captured using a monochromator. ] i in response to treatment was calculated from the difference in the peak change in amplitude from baseline. Only cells which had amplitudes 5% > than baseline and responded to a brief 80 mM KCl exposure were used for calculations. Data analysis was performed using a custom analysis program created in MatLab (TheMathWorks).
Electrophysiology
Cortical neurons were continuously perfused with saline solution containing the following (in mM) 140 NaCl, 4.7 KCl, 1.2 MgCl 2 , 2.5 CaCl 2 , 11 D-Glucose and 10 HEPES, adjusted to pH 7.4 with 1 M NaOH. For perforated patch experiments, the recordings were performed at room temperature with gramicidin (20 mg/ml). The recording electrodes contained the following (in mM) 140 KCl and 10 HEPES, adjusted to 7.4 with 1 M KOH. To determine the reversal potential of GABA A receptor-mediated currents (E GABA ), we voltageclamped neurons at specified holding potentials (10 mV increments in either direction beginning at -60 mV) before and after the application of GABA A R agonist muscimol. Experiments were performed with bath application of TTX (1 mM), DNQX (10 mM) and AP5 (40 mM) to block voltage-gated sodium channels, AMPA receptors and NMDA receptors, respectively. Muscimol (10 mM) was applied through a pico-spritzer electrode placed 50e100 mm away from the neuron of interest. Recordings were started after the establishment of an access resistance below 30 MU, usually about 10 min after seal formation. For each cell, PSC-amplitudes were measured and plotted against holding potential. For miniature inhibitory postsynaptic current (mIPSC) data, the recordings were performed at 32 C. The recording electrodes contained the following (in mM) 140 CsCl, 0.1 CaCl 2 , 2 MgCl 2 , 2.5 Phosphocreatine, 1.1 EGTA, 2 ATP-Mg, 1 GTP-Na and 10 HEPES, adjusted to 7.2 with 1 M CsOH. Cells were held at À60 mV. mIPSCs were recorded in the presence of TTX (1 mM), DNQX (10 mM) and AP5 (40 mM) to block voltage-gated sodium channels, AMPA receptors and NMDA receptors, respectively. To detect mIPSCs, obtained from 2-minlong continuous recordings, the threshold for event detection was set at 3 Â root mean square noise level. Software-detected events were visually verified, and their frequency, amplitude, 10-90% rise time and decay time were measured. The decay phase of averaged mIPSCs were fitted to a mono exponential decay function in Mini Analysis Program. In a subset of recordings, neurons were preincubated for 10 min in MEK inhibitor U0126 (1 mM), followed by 30 min in saline containing muscimol (50 mM). For tonic inhibition, the positive allosteric GABA A R modulator flurazepam (3 mM) was applied along with the above blockers and later bicuculline (50 mM) was applied through a pico-spritzer electrode. For tonic current measurements, an all-points histogram was plotted for approximately a 10-s period immediately before and during application of bicuculline (50 mM). Tonic currents are represented as the change in baseline amplitude, normalized to capacitance. We obtained all data using an Axon Multiclamp 700 B amplifier (Molecular devices) and Signal software (CED), filtered at 1-2 kHz and digitized at 10-20 kHz and stored digitally. Series resistance (R S ) was not compensated and experiments were discarded if R S changed by more than 20% during the recordings. Data processing was performed using Clampfit 10.3 (Molecular Devices), and Mini Analysis Program 6 (Synaptosoft) software.
Statistical analysis
For all studies, statistical analyses were performed using GraphPad Prism (GraphPad Software, San Diego, CA). Either unpaired t-tests, one way ANOVA, or two way ANOVA statistical tests with post hoc t-tests were used where appropriate, and are indicated in the text. All data are reported as mean ± SEM unless otherwise indicated.
Results
Identification of a depolarizing and inhibitory GABA A R response after the major phases of dendritic outgrowth and synaptogenesis
To identify the transition period from depolarizing excitation driven by GABA A R activation to when glutamatergic responses predominate, we performed calcium imaging experiments using the ratiometric dye Fura-2 AM. We compared [Ca 2þ ] i responses to glutamate and the GABA A R agonist muscimol from the period of GABAergic synaptogenesis (days in vitro DIV 5-7) to when these synapses have matured and glutamatergic synapses are established (DIV 13-15) (Craig et al., 1996; Danglot et al., 2003) . All experiments concluded with a final depolarizing KCl stimulus as a positive control for cell viability. Glutamate (20 mM) evoked a small [Ca 2þ ] i rise at DIV 5-7, with amplitudes and responses increasing by DIV 13-15 (Fig. 1A , B, C), in line with normal glutamatergic synapse development. Muscimol (50 mM) evoked a large [Ca 2þ ] i rise early in development (Fig. 1A , B, D). As expected with early excitatory GABAergic signaling, this [Ca 2þ ] i rise was completely blocked by the competitive GABA A R antagonist bicuculline (% cells responding:
neurons per treatment, t-test, ****p < 0.0001). Neurons at DIV 5-7 showed the highest [Ca 2þ ] i rise with muscimol treatment; as development proceeded, the response significantly diminished (Fig. 1A ,B, D). The overall decrease in muscimol evoked [Ca 2þ ] i response in older neurons is due to both smaller response amplitudes and a decrease in the number of events (Fig. 1E, F) . The muscimol evoked rise in [Ca 2þ ] i occurs primarily via L-type voltage gated calcium channels (VGCCs) as the L-type VGCC blocker nimodipine blocked the response in neurons of both ages ( Fig. 1 G, H, I: % cells responding at DIV 5 Musc ¼ 86 ± 4, Musc þ nimodipine ¼ 35 ± 10, n ¼ 71-169 neurons per treatment, ttest, ****p < 0.0001; % cells responding at DIV 13 Musc ¼ 33 ± 8%, Musc þ nimodipine ¼ 0 ± 0%, n ¼ 56-93 neurons, t-test, **p < 0.01).
The muscimol evoked modest [Ca 2þ ] i rise observed in DIV 13-15 neurons suggests that GABA A R activity is still depolarizing, despite the initial expectation that GABA A R activity would have switched to a hyperpolarizing response and not result in a [Ca 2þ ] i rise. To unequivocally define the GABA A R response, we used gramicidinperforated patch recordings, a method that preserves endogenous intracellular Cl‾ concentration, to determine the reversal potential for GABA A R (E GABA ) and the resting membrane potential (V m ) at DIV 5-7 and DIV 13-15. We found that E GABA was depolarized relative to the resting membrane potential in neurons of both age ranges, indicating a depolarizing response ( Fig. 2A, B) . However, younger neurons exhibited more positive E GABA values than older neurons while the resting membrane potential was equivalent between the two ages of neurons (Fig. 2C ). These data indicate that young neurons are more depolarized by GABA A R activity, and that in older neurons, E GABA is still positive to V m producing a weak depolarization that is likely to shunt membrane conductance and inhibit overall excitability. This data is consistent with the diminished muscimol evoked [Ca 2þ ] i rise at DIV 13-15 seen in Fig. 1 . To test the functional effect of GABA A R activation on coincident glutamatergic activity we compared the glutamate induced [Ca 2þ ] i rise to the combined treatment of glutamate and muscimol in DIV 13-15 neurons and DIV 5-7 neurons. Muscimol cotreatment decreased the average glutamate response amplitude in older neurons, and had no effect on younger neurons (Fig. 2D) . The lack of an additive effect of glutamate and muscimol depolarizing effects in young neurons likely results from maximal saturation of the Fura signal with the agonist concentrations used. Finally, to confirm that prolonged muscimol treatment did not deplete intracellular chloride levels Mean ± SEM, n ¼ 13-57 neurons per DIV period, *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001, one-way ANOVA followed by Tukey's post hoc test). E, F. Amplitude histograms showing muscimol response range at DIV 5-7 (E) and DIV 13-15 (F). G-I. L-type VGCC blocker nimodipine (Nimod) block the muscimol responses in neurons of both ages: % cells responding at DIV 5-7 Musc ¼ 86 ± 4, Musc þ nimodipine ¼ 35 ± 10, n ¼ 71-169 neurons per treatment, t-test, ****p < 0.0001; % cells responding at DIV 13-15 Musc ¼ 33 ± 8%, Musc þ nimodipine ¼ 0 ± 0%, n ¼ 56-93 neurons, t-test, **p < 0.01. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) ([Cl‾] i ), produce chloride unloading and abolish the depolarizing response, particularly in young neurons where the driving force on chloride is greater, calcium imaging experiments were performed after 30 min muscimol exposure, followed by a brief 2 min washout period. Comparison of t0 or t30 muscimol treatment (Fig. 2 E,F ] i produced by glutamate receptor activity.
Depolarizing and inhibitory GABA A R activity leads to delayed ERK activation
Very early in development, GABA A R agonist application activates receptors tonically in young neurons (DIV 2-5) to produce excitation, a rise in [Ca 2þ ] i and rapid activation of ERK within minutes, a key step in circuit development (Obrietan et al., 2002) . Due to the muscimol induced low rise in [Ca 2þ ] i that persists after GABA A R and glutamatergic synapse establishment (Fig. 1) , we examined the effect of GABA A R signaling on ERK activation in neurons with established GABAergic synapses (DIV 13-15). With muscimol treatment, at t5 min, pERK levels were unchanged; however, at t30 min, there was a significant increase in pERK activation while total ERK levels were unchanged (Fig. 3A) . We observed a similar effect of muscimol treatment on acute cortical Mild GABA A R induced depolarization inhibits neuron excitability. A,B, Representative gramicidin-perforated patch clamp recordings and I-V plots of normalized muscimolactivated currents from neurons in voltage clamp at DIV 5-7 and DIV 13-15. C. The reversal potential for muscimol elicited currents (E GABA ) in DIV 13-15 neurons was more negative compared to DIV 5-7 (DIV 5-7 ¼ -30.9 ± 6.7 mV, DIV 13-15 ¼ -50.0 ± 6.6 mV), while resting membrane potential (V m ) was unchanged (DIV 5-7 V m ¼ -66.1 ± 2.7 mV, DIV 13-15 V m ¼ -69.2 ± 4.5 mV). Mean ± SD, n ¼ 7 neurons for each age, ***p < 0. Representative calcium imaging data at t0 and t30 (after 30 min muscimol treatment). F. The % cells responding at DIV 5 were unchanged by muscimol treatment (n ¼ 89-126 neurons) and the % cells responding increased slightly with muscimol treatment in DIV 9-13 neurons: t0 ¼ 40.6 ± 5, t30 ¼ 62.8 ± 8 (Mean ± SEM, n ¼ 42-82 neurons, *p < 0.05). Fig. 3 . GABA A R activity regulates ERK activation. A. Representative immunoblot and analysis of time course for ERK phosphorylation following muscimol treatment at 13-15 DIV. pERK immunoreactivity at t30 was increased compared to t0 (t0 ¼ 100%, t5 ¼ 115 ± 9%, t30 ¼ 130.4 ± 7%, mean ± SEM, n ¼ 6-9 cultures, t30 compared to t0 *p < 0.05, one way ANOVA, Tukey's multiple comparisons test). Total ERK levels were unchanged (t0 ¼ 100%, t5 ¼ 100 ± 12%, t30 ¼ 106 ± 7%, mean ± SEM, n ¼ 6-9 cultures) B. pERK levels were similarly increased in postnatal day 13 rat acute cortical slices: pERK t0 ¼ 100%, t5 ¼ 103 ± 6%, t30 ¼ 120 ± 3%. Total ERK levels were unchanged (t0 ¼ 100%, t5 ¼ 112 ± 8%, t30 ¼ 104 ± 9%. mean ± SEM, n ¼ 4 independent animals, *p < 0.05, one way ANOVA, Tukey's multiple comparisons test. C. Representative immunostaining for pERK and total ERK at t0 and t30 muscimol treatment. Scale bars are 20 mm. Quantification of sum fluorescence intensities, normalized to t0. pERK values increased: t0 ¼ 100 ± 2%, t30 ¼ 121 ± 3 (Mean ± SEM, n ¼ 59-61 neurons, t0 v t30 ****p < 0.0001, t-test). D. TTX does not block the muscimol-dependent pERK increase in DIV 13-15 neurons. Neurons were pre-treated slices from postnatal day 13 rats (P13) (Fig. 3B) . Quantification of pERK and total ERK levels in cortical neurons using immunofluorescence also showed a significant increase in pERK at t30 with no difference in total ERK levels (Fig. 3C ). To confirm that the increase in pERK levels in older neurons was solely due to GABA A R signaling and not overall changes in network signaling, we pretreated cortical neuron cultures with 1 mM TTX for 5 min, then examined muscimol induced changes in pERK levels at t0 and t30 min. TTX pretreatment did not block the GABA A R dependent pERK increase (Fig. 3D) , indicating that enhanced ERK phosphorylation was due to GABA A R activation and not overall network activity. In addition, shorter muscimol treatment produced a similar level of ERK activation at t30: a brief 1 min muscimol treatment was followed by washout and evaluation of total and phospho ERK levels at t30 (Fig. 3E) . Finally, consistent with the calcium imaging data indicating a shunting inhibitory GABA A R response that dampens coincident glutamatergic activity (Fig. 2) , receptor blockade with the GABA A R antagonist bicuculline led to rapid and robust ERK activation (Fig. 3F ) similar to glutamate treatment alone (data not shown). This inhibitory role for GABA A R is well documented, as antagonist treatment (bicuculline or picrotoxin) is a standard means of robustly increasing excitatory synaptic activity and activating ERK in a glutamate receptor dependent manner (Bateup et al., 2013; Ivanov et al., 2006; Wiegert et al., 2007; Zhou et al., 2009 Zhou et al., , 2013 . Together with the calcium imaging and electrophysiological results, this biochemical data indicates that well after GABAergic synapse maturation, agonist application produces a depolarizing GABA A R response that leads to delayed ERK activation and minimizes overall cell excitability.
Sustained agonist exposure induces structural plasticity at GABAergic synapses
To assess the effects of muscimol treatment on GABA A R synaptic plasticity, we used immunofluorescence and confocal microscopy to examine key components of the GABAergic synapse: surface g2-containing GABA A Rs, the gephyrin synaptic scaffold and the presynaptic GABAergic terminal marker glutamic acid decarboxylase 65 which is responsible for local GABA synthesis (GAD65). Neurons undergoing either 0 or 30 min muscimol treatment were fixed and stained under non-permeabilizing conditions for surface g2 GABA A R, then permeabilized and stained for GAD65 (Fig. 4A) . Muscimol treated neurons exhibited a significant decrease in synaptic localization of surface g2 GABA A R, as determined by colocalization with GAD65 (Fig. 4B) . As the majority of g2 GABA A Rs detectable by immunofluorescence are clustered at synapses, this resulted in a decrease in total dendritic surface g2 GABA A R (Fig. 4B) .
There was also a significant decrease in presynaptic GAD65 (Fig. 4B) , indicating that muscimol exposure initiates presynaptic plasticity. In contrast to the GAD isoform GAD67, which is diffusely present throughout the neuron and is required for basal GABA synthesis, GAD65 is synaptically localized and has been shown to modulate GABAergic neurotransmission in response to changes in demand (Tian et al., 1999) .
Next we examined if muscimol exposure altered the gephyrin postsynaptic scaffold. mCherry-tagged gephyrin expressing neurons (Brady and Jacob, 2015) were used in fixed immunofluorescence experiments with presynaptic GABAergic terminals immunolabeled with the vesicular inhibitory amino acid transporter (VIAAT -GABA/glycine transporter). Muscimol treatment decreased the synaptic and total dendritic sum fluorescence intensity of gephyrin clusters (Fig. 4D) . In addition, the density of gephyrin clusters decreased with muscimol exposure (t0 ¼ 3.18 ± 0.18 clusters/10 mm, t30 ¼ 2.56 ± 0.17 clusters/10 mm, n ¼ 42-43 neurons, *p < 0.05, t-test). VIAAT levels were unaltered (Fig. 4D ) in contrast with GAD65 ( Fig. 4A) , suggesting that 30 min of muscimol treatment selectively affects GAD65, potentially decreasing GABA synthesis or the strength of GAD65 positive presynaptic terminals. In order to readily measure overall changes in surface GABA A R including both diffusely localized extrasynaptic and synaptically clustered receptors, we performed additional fixed immunofluorescence experiments staining for almost all GABA A R with a surface b2/3 subunit antibody. Measurements of total dendritic surface b2/ 3 showed no significant change (Fig. 4F) . Consistent with the earlier analysis (Fig. 4D) , VIAAT levels were unchanged (Fig. 4E, F) . Interestingly, the sum fluorescence intensity of synaptic b2/3 increased (Fig. 4F) , suggesting increased synaptic levels of another receptor subtype that is non g2 subunit containing. This indication of GABA A R exchange at synapses is consistent with single particle tracking experiments showing increased movement of receptors between extrasynaptic and synaptic domains with decreased gephyrin scaffolding (Petrini et al., 2014; Renner et al., 2012) . As an alternative method for measuring surface total GABA A R changes, we examined the levels of surface g2 and b GABA A R subunits using cell-surface biotinylation. TTX treatments were additionally included in these experiments to show the specific requirement for GABA A R activation, rather than a change in general network activity. Cell-surface biotinylation experiments did not detect any significant changes in surface levels of either g2 or b3 subunits after 30 min of muscimol treatment (Fig. 4G) . Furthermore, analysis of neuron lysates by western blot showed no changes in total protein levels of g2 or b3 (Fig. 4H ). Together these data indicate that during muscimol exposure there is a decrease in synaptic gephyrin and a shift in surface localization of GABA A R subtypes, with g2 GABA A Rs moving out of synapses and movement of b2/3 containing non-g2 GABA A Rs into the synapse.
Muscimol treatment decreases synaptic currents while enhancing GABA A R tonic current in an ERK-dependent manner
Given the robust effect of GABA A R agonist treatment on structural synaptic plasticity, the effect of muscimol on the efficacy of synaptic inhibition was determined. Analysis of miniature inhibitory postsynaptic currents (mIPSCs) in cultured cortical neurons was performed following muscimol treatment using whole cell patch-clamp recordings. To evaluate the role of muscimol evoked ERK activation in modulating GABAergic neurotransmission, additional experiments were conducted with the MEK/ERK inhibitor U0126. Muscimol exposure significantly decreased mIPSC amplitude, and U0126 blocked this decrease (Fig. 5A,B) . Muscimol treatment also prolonged the decay of mIPSCs in an ERK dependent manner (Fig. 5A,B) . Both the decrease in mIPSC amplitude and increase in decay are consistent with loss of synaptic g2 GABA A R as seen in the immunofluorescence data presented here (Fig. 4) and reported with genetic knockout or knockdown of g2 or gephyrin (Essrich et al., 1998; Kerti-Szigeti et al., 2014) . Neither muscimol treatment nor ERK inhibition altered mIPSC frequency, suggesting presynaptic release of GABA containing vesicles is unaltered (mIPSC frequency: t0 ¼ 2.8 ± 0.4 Hz, t30 ¼ 2.7 ± 0.4 Hz, with 1 mM TTX, and then treated for either 0 or 30 min with muscimol. t0 eTTX ¼ 100%, t0 þTTX ¼ 108 ± 3, t30 eTTX ¼ 126 ± 4, t30 þ TTX ¼ 126 ± 3 (mean ± SEM, n ¼ 3 cultures, **p < 0.01, two-way ANOVA and post hoc t-tests). E. 1 min muscimol treatment followed by washout produced similar ERK activation to 30 min muscimol treatment: t0 ¼ 100%, t30 (1min Musc þ 29 min washout) ¼ 156.3 ± 11 ((Mean ± SEM, n ¼ 3 cultures,*p < 0.05, unpaired t-test). F. Bicuculline rapidly increases pERK immunoreactivity in DIV 13-15 neurons: t0eBIC ¼ 100.0%, t0þBIC ¼ 201 ± 39 (Mean ± SEM, n ¼ 6-9 cultures, *p < 0.05, unpaired t-test). t30 þ U0126 ¼ 2.8 ± 0.4 Hz). The lack of change in frequency suggests that the GAD65 decrease does not dramatically or immediately impact GABA release levels when assessed by mIPSCs. Similarly, neuron cultures from GAD65 knockout animals do not show basal spontaneous IPSC frequency or amplitude deficits, however GABA release is reduced under conditions of sustained synaptic activation (Tian et al., 1999) .
Due to the possibility of agonist induced changes in GABA A R localization also altering the tonic current, whole-cell patch clamp recordings were next used to assess changes in extrasynaptic receptor activity. Holding current was measured with the addition of the benzodiazepine flurazepam to enhance tonic current detection. Bath application of the GABA A R competitive antagonist bicuculline dramatically decreased the whole-cell holding current in neurons treated with muscimol, compared to control and U0126 pretreated neurons (Fig. 5C,D) . Whole-cell current change, measured as a difference between baseline before and after bicuculline application was 1.5 ± 0.1 pA/pF for control t0, 3.0 ± 0.4 pA/pF for t30 min muscimol, and 1.6 ± 0.4 pA/pF for t30 min muscimol þ U0126 (Fig. 5C,D) . This data revealed that muscimol treatment enhanced the overall tonic current in an ERK dependent manner.
As the decrease in synaptic g2 and gephyrin levels suggests movement of g2 GABA A R into extrasynaptic areas (Fig. 4) , we next separately examined the g2 containing component of the tonic current (Fig. 6) . In addition to their predominant role in synaptic GABA A R neurotransmission, g2 containing receptors are also found at lower levels at extrasynaptic sites and contribute to tonic current that is sensitive to positive allosteric modulation by the benzodiazepine drug class (Brady and Jacob, 2015; Nusser et al., 1998; Somogyi et al., 1996) . We used the benzodiazepine flurazepam (3 mM) which binds at the interface of g2 with a1, 2, 3, or 5 subunits to specifically detect enhancement of g2 GABA A R tonic current. In agreement with a higher level of g2 GABA A R in extrasynaptic Fig. 4 . Muscimol treatment results in GABAergic synaptic plasticity. A. DIV 13-15 neurons treatedwith muscimol for 0 or 30 min, fixed, stained for surface g2, then permeabilized and stained for GAD65. B. Quantification of sum fluorescence intensity of synaptic surface g2 levels (t0 ¼ 100 ± 10%, t30 ¼ 70 ± 7%), surface total g2 (t0 ¼ 100 ± 12%, t30 ¼ 67 ± 7%), and total levels of GAD65 (t0 ¼ 100 ± 8%, t30 ¼ 76 ± 8%). n ¼ 40-42 neurons, *p < 0.05, t-test. C. mCherry-gephyrin neurons treated with muscimol for 0 or 30 min, then fixed, permeabilized, and stained for gephyrin and VIATT. D. Muscimol treatment decreased the sum fluorescence intensity of synaptic gephyrin clusters (synaptic fluorescence t0 ¼ 100 ± 8%, t30 ¼ 71 ± 8%, *p < 0.05) and total gephyrin clusters (total fluorescence t0 ¼ 100 ± 8%, t30 ¼ 72 ± 6%,*p < 0.05, n ¼ 41-42 neurons, t-test), with no changes in total VIATT. E. DIV 13-15 neurons treated with muscimol for either 0 or 30 min, fixed, stained for surface b2/3, then permeabilized and stained for VIATT. A,C,E: scale bars 20 mm, and 2 mm on enlargements. F. Muscimol treatment induced an increase in synaptic b2/3 sum fluorescence intensity (t0 ¼ 100.0 ± 8%, t30 ¼ 137.1 ± 13%, *p < 0.05, n ¼ 44-45 neurons, t-test), with no changes in total b2/3 or VIATT sum intensities. G, H. Neurons were surface biotinylated and lysed in RIPA. Immunoblots show that surface and total protein levels of g2 and b3 subunits, either with or without TTX were unchanged after muscimol (n ¼ 3-6 cultures, ns, two-way ANOVA).
regions, flurazepam significantly potentiated the holding current in muscimol treated neurons (Fig. 6A,B) . In neurons pretreated with U0126, flurazepam showed a lower potentiation of holding current that was equivalent to control neurons (t0 ¼ 0.61 ± 0.14 pA/pF, t30 ¼ 2.04 ± 0.39 pA/pF, t30 þ U0126 ¼ 0.46 ± 0.21 pA/pF). In summary, these functional data combined with biochemical and imaging results indicate that muscimol treatment via ERK activation induces GABAergic postsynaptic plasticity that diminishes g2 GABA A R and gephyrin synaptic localization, resulting in decreased synaptic currents while concurrently increasing g2 GABA A R tonic current.
GABA A R dependent activation of ERK relies on MEK, intracellular calcium release, and BDNF
To investigate the mechanisms contributing to muscimol induced GABAergic synaptic plasticity we first used U0126 to confirm that muscimol treatment leads to MEK and ERK activation. Pretreatment with U0126 decreased basal ERK activation and completely blocked muscimol induced ERK activation (Fig. 7A) . We next assessed the calcium dependence of muscimol induced ERK activation as GABA A R mediated depolarization could result in calcium influx via L-type VGCCs and calcium release from intracellular stores, activating Ras and leading to ERK phosphorylation (Rosen et al., 1994) . A 10 min pretreatment with the L-type VGCCs blocker nimodipine did not block the muscimol dependent increase in pERK (Fig. 7B) . As other VGCCs could be involved, we next excluded Ca 2þ from the extracellular medium and examined ERK activation. Exclusion of extracellular Ca 2þ did not prevent the muscimol induced increase in pERK levels (Fig. 7C) . In contrast, a well characterized synaptic stimulation protocol using brief KCl depolarization required extracellular Ca 2þ influx to activate ERK Fig. 5 . Muscimol treatment decreases synaptic currents and concurrently increases the tonic current in an ERK-dependent manner. A. Whole-cell recordings of mIPSCs from DIV 13-15 neurons. Neurons were incubated in standard extracellular saline containing TTX, DNQX, and APV to isolate GABA A R currents for t ¼ 0 min (t0), in saline containing muscimol for 30 min (t30), or pretreated with 1 mM U0126 for 10 min then treated with muscimol for 30 min(t30 þ U0126), then mIPSC recordings were performed in saline. B. Muscimol treatment decreased mIPSC amplitudes which was blocked by U0126 pretreament: t0 ¼ 57.9 ± 0.6 pA, t30 ¼ 37.2 ± 0.4 pA, t30 þ U0126 ¼ 55.8 ± 1.0 pA. Muscimol treatment slowing of mIPSC decay was blocked by U0126: t0 ¼ 15.5 ± 0.6 ms, t30 ¼ 20.5 ± 0.9 ms, t30 þ U0126 ¼ 14.4 ± 0.7 ms (Mean ± SEM, n ¼ 7 neurons per condition, one way ANOVA, Tukey's multiple comparisons test). C. Tonic currents recorded from neurons treated as in A. with the addition of flurazepam (FLZ) to amplify GABA A R tonic currents. To identify the tonic current, bicuculline (BIC) was added. D. Muscimol treatment increased tonic current, which was blocked by U0126 pretreatment: in pA/pF t0 ¼ 1.5 ± 0.1, t30 ¼ 3.0 ± 0.4, t30 þ U0126 ¼ 1.6 ± 0.4 (Mean ± SEM, n ¼ 6-7 neurons per condition, one way ANOVA, Tukey's multiple comparisons test). *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001.
( Fig. 7D) , as previously shown (Dolmetsch et al., 2001; Rosen et al., 1994) . Therefore depolarization of the membrane without altering [Cl‾] i results in an alternative mechanism of ERK activation. GABA A R dependent ERK activation shown here is also mechanistically distinct from AMPA receptor or NMDA receptor activation, which require extracellular calcium influx (typically via VGCC, NMDAR or calcium permeable AMPAR, reviewed in (Thomas and Huganir, 2004) ) to stimulate Ca2þ release from stores and rapidly activate ERK (Perkinton et al., 1999; Tian and Feig, 2006; Zhou et al., 2009) . Recent studies indicate that depolarization in the absence of extracellular Ca2þ can trigger internal stores Ca2þ release in a variety of neuron subtypes (Billups et al., 2006; De Crescenzo et al., 2006; Kim et al., 2007; Ryglewski et al., 2007; Sun et al., 2016) . To determine whether depolarizing GABA A R stimulation was releasing intracellular Ca 2þ stores and activating ERK, we depleted endoplasmic reticulum (ER) Ca 2þ stores with a 60 min pretreatment of thapsigargin in combination with BAPTA-AM to chelate intracellular Ca 2þ . Depletion of intracellular Ca 2þ stores (TGBA) prevented muscimol-dependent ERK activation (Fig. 7E) . The intracellular calcium chelator BAPTA-AM does not affect extracellular Ca 2þ , as rapid glutamate-dependent ERK activation is not blocked with TGBA treatment (data not shown). Together, these data indicate that in neurons with established synapses and a depolarizing, inhibitory GABA A R response, delayed ERK activation relies on intracellular Ca 2þ release from the ER that is not dependent on extracellular Ca 2þ influx. We next examined the effects of BDNF activity on muscimol-dependent ERK activation, as GABA A R activity early in development can lead to BDNF release (Porcher et al., 2011) and exogenous BDNF can induce ERK activation (Obrietan et al., 2002; Tokuoka et al., 2000) . Pretreatment with 10 mM ANA-12, a potent and specific TrkB inhibitor (Cazorla et al., 2011) did not alter basal pERK levels but significantly blocked muscimol-dependent ERK activation (Fig. 7F) . In summary, our biochemical data show that GABA A R dependent ERK activation can be blocked with the MEK/ERK inhibitor U0126 and also by the TrkB inhibitor ANA-12 (Fig. 7) , implicating these two signaling pathways. Furthermore, in contrast to KCl depolarization dependent activation of ERK which relies upon extracellular Ca2þ influx to release calcium stores (as also seen with AMPA and NMDA receptor signaling), GABA A R agonist activation of ERK via intracellular stores is independent of extracellular Ca2þ.
ERK activation contributes to muscimol evoked post but not presynaptic GABAergic synapse plasticity
Thus far we have shown that muscimol treatment in neurons Fig. 6 . Benzodiazepine sensitive g2 containing GABA A R tonic current is enhanced by muscimol treatment. Neurons were incubated in standard extracellular saline containing for t ¼ 0 min (t0), in saline containing muscimol for 30 min (t30), or pretreated with 1 mM U0126 for 10 min then treated with muscimol for 30 min (t30 þ U0126). A. Baseline currents were recorded in extracellular saline containing TTX, DNQX, and APV, followed by perfusion of flurazepam (FLZ). Benzodiazepine sensitive tonic current was expressed as the difference in baseline current before and after application of FLZ (3 mM). After subtracting baseline from the current evoked by FLZ, the tonic current was normalized to cell size.
Representative traces with corresponding all-point histograms fitted with single Gaussian functions are shown. B. Muscimol treatment increased the g2 containing GABA A R contribution to tonic current, which was blocked by U0126 pretreatment: in pA/pF t0 ¼ 0.61 ± 0.14, t30 ¼ 2.04 ± 0.39, t30 þ U0126 ¼ 0.46 ± 0.21 (Mean ± SEM, n ¼ 6-7 neurons per condition, one way ANOVA, Tukey's multiple comparisons test). *p < 0.05, **p < 0.01.
with established GABAergic synapses decreases synaptic GABA A R currents while enhancing g2 tonic current in an ERK dependent manner. We have also observed muscimol induced structural plasticity at GABA A R synapses, leading to a decrease in g2 and gephyrin synaptic clustering, and lowering of GAD65 levels. To further dissect the mechanisms contributing to this GABAergic synaptic plasticity we first evaluated the role of ERK using fixed immunofluorescence and confocal microscopy. After pretreating ± U0126 followed by muscimol treatment, neurons were immunostained for surface g2 containing GABA A R, then permeabilized and stained for GAD65 and gephyrin (Fig. 8A) . ERK inhibition with U0126 blocked the muscimol-induced decrease in total g2 surface levels (Fig. 7C ) but did not restore g2 synaptic levels (Fig. 8B) . This data suggests that ERK activation contributes to GABA A R activity dependent postsynaptic plasticity, along with additional pathways regulating g2 synaptic clustering. Muscimol treatment significantly decreased endogenous synaptic gephyrin levels (Fig. 8B) , consistent with earlier results using tagged gephyrin (Fig. 4C,D) . The lack of a change in total gephyrin levels ( Fig. 8C) suggests dispersal of gephyrin away from synapses and a more diffuse organization of the scaffolding, likely to have been undetected in experiments with tagged gephyrin. The loss of synaptic gephyrin was blocked by MEK/ERK inhibition with U0126, indicating that gephyrin reorganization occurs downstream of muscimol-dependent ERK activation (Fig. 8B) . In contrast, U0126 treatment did not block the muscimol induced decrease in GAD65 levels (Fig. 8C ). Together these data suggest that the effects of muscimol-dependent ERK activation are confined to postsynaptic changes leading to loss of synaptic gephyrin and surface g2 clusters, with pre-synaptic changes occurring through a separate signaling mechanism.
3.7. BDNF signaling supports agonist induced post and pre synaptic structural plasticity at GABA A R synapses
As we had observed that muscimol-dependent ERK activation could be blocked by an inhibitor of BDNF and TrkB signaling (Fig. 7E , ANA-12), we next assessed the contribution of BDNF signaling to GABA A R dependent synaptic plasticity. We pretreated neurons with the TrkB inhibitor ANA-12 for 30 min followed by muscimol exposure. As before, neurons were stained for surface g2 subunit levels, then permeabilized and stained for GAD65 and gephyrin (Fig. 9A) . TrkB inhibition blocked the decrease in synaptic and total surface levels of g2 GABA A R (Fig. 9B-C) . Total gephyrin levels were significantly decreased by muscimol treatment and synaptic levels trended towards a decrease, with TrkB inhibition resulting in no clear rescue of the loss of gephyrin (Fig. 9B-C) . In contrast, TrkB inhibition completely restored GAD65 levels to control values (Fig. 9C ). Together these data support a role for ERK and BDNF signaling in the dispersal of g2 GABA A R from synapses, while gephyrin declustering is mediated by ERK alone. Furthermore, muscimol treatment induces BDNF signaling that triggers a decrease in presynaptic GAD65, likely through dendritic BDNF release acting onto presynaptic terminals (Singh et al., 2006) . Consistent with this data, TrkB receptors are found at GABAergic synapses, displaying colocalization with GAD65 presynaptically and g2 containing GABA A R postsynaptically (Swanwick et al., 2004) .
Discussion
Despite the critical role of GABA and activity dependent plasticity in neuronal circuit development, most studies have examined modulation of excitatory glutamatergic synapses on principal cells. However, recent reports have identified plasticity mechanisms at GABAergic synapses on pyramidal cells and interneurons, revealing that dynamic modulation of these synapses is of fundamental importance (Barberis and Bacci, 2015) . The majority of investigations of GABAergic postsynaptic plasticity have focused on excitation driven changes. For example, NMDA receptor activation can bidirectionally modulate GABAergic postsynaptic strength and receptor clustering through regulation of phosphatase (Bannai et al., 2009) or CaMKII activity (Marsden et al., 2010; Petrini et al., 2014) . In this study we have identified and provided mechanistic insight into GABA A R agonist dependent rapid pre and postsynaptic GABAergic plasticity, summarized in Model Fig. 10 . First, we demonstrate that at DIV 13-15, well after the major phases of dendritic outgrowth and synaptogenesis, cortical neurons weakly depolarize in response to muscimol treatment, inhibiting cell excitability and leading to delayed ERK activation at 30 min. This cellular response is distinct from early excitatory depolarizing GABA A R activity that generates a large [Ca 2þ ] i increase and rapidly activates ERK (Obrietan et al., 2002) . Next, we show that muscimol exposure decreases synaptic localization of surface g2 GABA A Rs and gephyrin while b2/3 non-g2 GABA A Rs accumulate in the synapse. This structural plasticity is matched by an ERK dependent decrease in synaptic GABA A R currents and a concurrent enhancement in the tonic current from extrasynaptic g2 containing benzodiazepine sensitive GABA A R. These results complement a recent single particle tracking study in mature hippocampal neurons that showed muscimol treatment enhanced GABA A R and gephyrin diffusion away from synapses, while antagonist treatment reduced diffusion (Gouzer et al., 2014) . Furthermore, GABA A R diffusion was unaffected by both NMDA-and AMPA-type glutamate receptor blockade, and hence independent of excitatory glutamatergic activity. Together with our data these observations suggest that ligand binding induces changes in GABA A R conformation and receptor scaffold interactions that are a critical means for controlling GABA A R signaling.
Mechanistically, we show that muscimol-dependent ERK activation is independent of extracellular calcium influx, but relies on release of intracellular calcium stores. This ERK activation contrasts that occurring with both synaptic stimulation protocols (brief KCl depolarization, shown here) and AMPAR or NMDAR activation which rely on extracellular calcium entry via NMDAR, VGCC or calcium permeable AMPAR to induced release of intracellular calcium stores and activate ERK. Recent studies during the last decade have identified that depolarization in the absence of extracellular Ca2þ can trigger internal stores Ca2þ release in a variety of neuron subtypes (Billups et al., 2006; De Crescenzo et al., 2006; Kim et al., 2007; Ryglewski et al., 2007; Sun et al., 2016) . Mechanisms identified include voltage-induced Ca2þ release from internal stores via IP3 receptors (Ryglewski et al., 2007; Sun et al., 2016) and L-type VGCC direct gating of the ryanodine receptor in hippocampal (Kim et al., 2007) and hypothalamic neurons (De Crescenzo et al., 2006) . As we show that GABA A R agonist activation of ERK is not blocked by Fig. 8 . Pretreatment with the ERK inhibitor U0126 blocks muscimol-induced postsynaptic plasticity events. A. DIV 13-15 neurons were pretreated with either U0126 or DMSO vehicle control then treated with muscimol. Neurons were fixed, stained for surface g2 levels, then permeabilized and stained for intracellular gephyrin and GAD65. Scale bars 20 mm, and 2 mm on enlargements. B. Synaptic immunofluorescence analysis and C. Total dendritic immunofluorescence analysis. Mean ± SEM, n ¼ 42-44 neurons, two-way ANOVA and post hoc t-tests. *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001. Fig. 9 . Pretreatment with the BDNF/TrkB inhibitor ANA-12 prevents muscimol-induced decreases in synaptic g2 GABA A R clustering and GAD65 levels. A. DIV 13-15 neurons were pretreated with either 10 mM ANA-12 or DMSO vehicle control then treated with muscimol. Neurons were fixed, stained for surface g2 levels, then permeabilized and stained for gephyrin and GAD65. Scale bars 20 mm, and 2 mm on enlargements. B. Synaptic immunofluorescence analysis and C. total dendritic immunofluorescence analysis. Mean ± SEM, n ¼ 56-58 neurons, two-way ANOVA and post hoc t-tests. *p < 0.05, **p < 0.01, and ***p < 0.001. Fig. 10 . Model for muscimol induced GABAergic synaptic plasticity. Synaptic GABA release in neurons with established synapses produces mild depolarization via chloride efflux and low release of intracellular Ca 2þ from ER stores, resulting in low pERK levels and minimal BDNF stimulation. Prolonged exposure to muscimol enhances depolarization (1) and increases Ca 2þ store release (2), potentially via a Ca 2þ influx independent voltage sensor. Ca 2þ store release in turn activates ERK above baseline (3) and promotes release of dendritic BDNF (4). Enhanced pERK activity decreases synaptic g2 GABA A R and gephyrin, leading to higher extrasynaptic g2 GABA A R levels (3). BDNF signaling contributes to the decrease in synaptic g2 GABA A R (4), as well as diminishing presynaptic GAD65 levels (5).
nimodipine, this may rule out the latter mechanism, although incomplete blockade of VGCC by dihydropyridine antagonists could be a confound (Lipscombe et al., 2004; Xu and Lipscombe, 2001) . A possibility for muscimol treatment induced intracellular calciumrelease could be a membrane voltage sensor activating IP3 to induce internal store calcium-release (Fig. 10) . Future experiments will need to be performed for more detailed identification of the specific stimuli responsible for GABA A R depolarization induced release of calcium stores. Downstream of muscimol induced depolarization, biochemical and imaging experiments identified ERK and BDNF signaling as regulating the dispersal of g2 GABA A R from synapses, while synaptic gephyrin declustering is mediated by ERK alone. In contrast to the agonist induced downregulation of GABAergic synapse strength we show here, muscimol stimulation in young neurons (DIV 6) with excitatory GABA polarity promotes BDNF release and insertion of GABA A Rs (Porcher et al., 2011) . In addition to this postsynaptic plasticity, we show that muscimol induces a presynaptic decrease in GAD65 levels via BDNF/TrkB signaling, likely through dendritic BDNF release and retrograde signaling. Prior studies examining presynaptic plasticity have focused on long-term effects, with the predominant observation that reduced neuronal activity leads to a homeostatic decrease in GAD65: 1) modulation of neuronal activity over days regulates GAD expression bidirectionally in a homeostatic manner via both BDNF dependent and independent pathways (Hanno-Iijima et al., 2015) , 2) in vivo experimental manipulations that decrease activity (visual deprivation) lead to decreased GAD65 puncta which can be rescued by activity restoration (re-exposure to light) (Kreczko et al., 2009) , and 3) chronic activity blockade (24 -48 h TTX treatment) homeostatically alters pre and postsynaptic GABAergic synapse plasticity, decreasing GABA A R synaptic clusters, mIPSC amplitude and frequency (Kilman et al., 2002) . Importantly, we observe a muscimol dependent decrease in GAD65 levels within 30 min. It is likely that with the shorter timescale of our experiments, GAD65 levels are not sufficiently depleted to produce a change in mIPSC frequency. This is consistent with the lack of basal IPSC frequency deficits in neuron cultures from GAD65 knockout animals (Tian et al., 1999) in contrast to GAD67 knockouts that have a >90% reduction in basal GABA brain levels and exhibit neonatal lethality (Asada et al., 1997) . In further support of our findings showing muscimol induced GABAergic synapse plasticity occurring via BDNF signaling, exogenous BDNF has also been shown to decrease presynaptic GABA release and postsynaptic GABA A R response (Brunig et al., 2001; Lemtiri-Chlieh and Levine, 2010) .
In summary, this study identifies a key role for agonist induced plasticity in regulation of GABAergic synapse development and defines intracellular signaling pathways downstream of receptor activation that contribute to these events. These findings suggest that as neurons transition from depolarizing, excitatory GABA A R signaling towards an inhibitory, hyperpolarizing response, a key intermediate phase with depolarizing and inhibitory GABA A R activity prevents overexcitation while also restraining GABAergic synapse growth and strength to promote circuit development. This mechanism could be particularly relevant to early in vivo plasticity, as two recent studies have demonstrated that GABA primarily depolarizes and inhibits network activity in the intact neonatal cortex around P3-P9 (Kirmse et al., 2015; Valeeva et al., 2016) . Interestingly, Kirmse et al. did not observe a hyperpolarizing response in vivo at P25-27, suggesting that shunting inhibition could be the main form of inhibition in the juvenile/adult cortex in vivo. Importantly, a recent report showed that in vivo muscimol treatment during early postnatal brain development led to increased anxiety-and depression-related behaviors in adult mice (Salari et al., 2015) , hallmarks of impaired GABAergic signaling. Clearly future work investigating the mechanisms of GABA A R synaptic plasticity induced by agonist and other allosteric drugs is merited.
